This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ahead of MetLife (MET) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of +2.35% and +19.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
by Zacks Equity Research
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Radian Hits 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
MetLife Teams Up With Sprout.ai to Advance Global Claims Automation
by Zacks Equity Research
MET taps Sprout.ai to speed up global claims processing, blending AI automation with human-centered service.
MetLife Broadens Upwise Reach Through Nayya and Workday Deal
by Zacks Equity Research
Taking Nayya's help, MET expands the reach of its Upwise platform by making it available via the Workday Marketplace. This is expected to boost uptake of Employee Benefit plans.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Is Assurant (AIZ) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is MetLife (MET) Up 4.1% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Radian Group Near 52-Week High: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
RDN stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
Zacks Industry Outlook Highlights MetLife, American International, Principal Financial, Everest and Assurant
by Zacks Equity Research
MetLife, American International, Principal Financial, Everest and Assurant have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancements and improving inflation are expected to aid multiline insurers like MET, AIG, PFG, EG and AIZ.
Top Analyst Reports for Oracle, IBM & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), IBM Corp. (IBM) and Merck & Co., Inc. (MRK), as well as a micro-cap stock Earth Science Tech, Inc. (ETST).
MetLife Q1 Earnings Lag Estimates on High Expenses, Soft Asia Unit
by Zacks Equity Research
MET's Q1 earnings were hurt by higher expenses, tax rate changes in Asia and weaker Latin America results, partly offset by strength in Group Benefits and EMEA segments.
MetLife (MET) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Lags Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -1.51% and 3.40%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From These 4 Insurers This Earnings Season?
by Debasmita Chatterjee
Strong premiums, M&A activities and tech efficiencies are likely to have aided insurers' Q1 performance, despite pressure from low interest rates, inflationary headwinds and catastrophe-related losses.
MET to Report Q1 Earnings: What Do the Key Estimates Say?
by Zacks Equity Research
MET's first-quarter results are likely to benefit from higher group benefit revenues.
Unlocking Q1 Potential of MetLife (MET): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of MetLife (MET) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: American International Group (AIG) Q1 Earnings Expected to Decline
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife Joins SKYGEN to Revolutionize Dental Provider Experience
by Zacks Equity Research
MET partners with SKYGEN to simplify dental credentialing, enhance efficiency, and improve the provider experience.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife's New Latin America Unit Generates 4.5M Active Customers
by Zacks Equity Research
By leveraging technology and a startup-like agile model, MET aims to scale operations across Latin America.